中国药物警戒 ›› 2011, Vol. 8 ›› Issue (10): 590-591.

• 临床研究 • 上一篇    下一篇

灯盏花素注射液临床应用安全性的初步评价

叶云, 张士勇, 程军, 王刚斌, 韩一萱   

  1. 蚌埠市第三人民医院药事办,安徽 蚌埠233000
  • 收稿日期:2011-02-15 出版日期:2011-10-10 发布日期:2015-07-30
  • 作者简介:叶云,男,硕士,药师,临床药学。
  • 基金资助:
    蚌科[2009]77）

Preliminary Safety Evaluation of Breviscapine Injection in Its Clinical Application

YE Yun, ZHANG Shi-yong, CHENG Jun, WANG Gang-bin, HAN Yi-xuan   

  1. Dept. of Pharmacy, The Third People's Hospital of Bengbu, Anhui Bengbu 233000, China
  • Received:2011-02-15 Online:2011-10-10 Published:2015-07-30

PDF (PC)

151

摘要： 目的 初步评价灯盏花素注射液的临床应用安全性。方法 调查统计我院2010年4~9月所有使用过灯盏花素注射液的住院患者病例和发生的不良反应,并分析其用药合理性与不良反应发生情况。结果 共收集使用过灯盏花素注射液的住院患者病例765例,共涉及9个科室,19种疾病。收集不良反应8例,占1.05%。严格按照说明书应用药物的不良反应发生较少。结论 严格按照药品说明书规定使用有利于提高灯盏花素注射液临床应用的安全性。

关键词: 灯盏花素注射液, 不良反应, 合理用药

Abstract: Objective To generally evaluate the clinical safety of the Breviscapine injection. Methods Collect and research on the cases of Breviscapine injection in my hospital during the period of April and September 2010. Results Based on the 765 inpatient cases which involved 9 department and 19-odd diseases,whilst ADR occurred in 8 cases(1.05% among the total). The rate of drug adverse reaction was reduced when the applications followed the drug instructions. Conclusion The safety of clinical application would be enhanced by accurate operations that are strictly in line with the instructions of treatment.

Key words: Breviscapine Injection, drug adverse reaction, rational drug use

中图分类号: